SCLEROSING cholangitis is a rare clinical entity. We found only 20 unequivocal cases reported in the past forty years. 1–3 A number of other reported cases do not meet the criteria for this entity.

PARIS — Statins can significantly reduce the risk for complications and death from primary sclerosing cholangitis, results from a Swedish registry study show. Primary sclerosing cholangitis is ...

Dublin, Jan. 25, 2021 (GLOBE NEWSWIRE) -- The "Primary Sclerosing Cholangitis - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. Primary Sclerosing ...

Ipsen’s elafibranor has shown promise as a treatment for primary sclerosing cholangitis (PSC), a rare liver disease that currently has no approved treatment options. Results from the phase 2 ELMWOOD ...

SOUTH SAN FRANCISCO, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel ...

Primary sclerosing cholangitis (PSC) is a progressive scarring of the liver's bile ducts. According to current estimates, ...

SOUTH SAN FRANCISCO, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel ...

This page lists all known medications that could potentially lead to 'Cholangitis sclerosing' as a side effect. It's important to note that mild side effects are quite common with medications. The ...